COVID-19: Detection Technologies and Neurological Impact
Conversations Between Academia and Industry
Bob Datta
Associate Professor of Neurobiology,
Harvard Medical School
Chris Mason
Co-founder, Biotia
Associate Professor,
Weill Cornell Medicine
Niamh O’Hara
Co-founder and CEO of Biotia
Moderated by:
David Brann
Graduate Student, Datta Lab
Harvard Medical School